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Purpose: The effect of solvent used in dissolving chitosan (membrane material) and the 
microcapsule drying method used, on protein retention in chitosan-alginate microcapsules 
were studied since these factors affect the physicochemical characteristics of the coating 
membrane.  
Method: The microcapsules were prepared by extruding a solution containing alginate and 
BSA into chitosan/calcium chloride solution prepared with different acid solvents – acetic acid, 
formic acid, tartaric acid and hydrochloric acid. A portion of the microcapsules was air-dried at 
ambient temperature while the remaining portion was freeze-dried. The elution of protein from 
the microcapsules in simulated gastric fluid was monitored spectrophotometrically at λmax 280 
nm. Results: Tartaric acid effected the highest mean protein retention (54%) after 9 h 
followed by acetic acid (35%), hydrochloric acid (31%) and formic acid, (30%). There appears 
to be a link between the pKa of the acids and the degree of chitosan–solvent interaction on 
the one hand, and protein retention on the other hand. Increase in elution pH from 1.2 to 5.0 
did not significantly (P>0.05) affect protein retention. Furthermore, there was no significant 
difference (p>0.05) between the protein retention capacities of air-dried and freeze-dried 
microcapsules as both types showed protein retention of 50% after 5 h.  
Conclusion: Tartaric acid was the most suitable solvent for enhancing protein retention in 
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Introduction 
Membrane coating is applied to solid dosage 
forms for a variety of reasons, including 
aesthetics 1, protection of drug from acid and 
enzymes in the gut 2, and environmental 
degradation 3, controlled drug release and site-
specific delivery 4. The choice of solvent in the 
preparation of coating solution is of particular 
importance because it affects the 
physicochemical characteristics of the 
encapsulating membrane and hence the final 
drug product. Polymer membrane parameters 
such as permeability, solubility and stability 3 as 
well as microcapsule properties such as size, 
swelling and drug release profile 5 have been 
reported to be influenced by the nature of the 
solvent used. Among the solvent properties that 
play a role in this regard are: viscosity, dielectric 
constant, polarity and pH 3, 5 & 6. In the food and 
drug industry, the final choice of solvent used is 
usually based on cost, source, availability and 
toxicity or safety profile of the solvent 1, which is 
often a part (even in residual amounts) of the 
final product. 
 
Chitosan is a naturally occurring polycationic 
polymer obtained from the N-deacetylation of 
chitin, found in the exoskeleton of crustaceans 
and insects6. It is freely available, cheap and has 
antifungal and bacteriostatic properties. 
Furthermore, because it is easily biodegradable, 
biocompatible and has great ease of chemical 
modification7, it has found a wide range of 
applications in pharmacy and medicine such as 
inhibition of tumor cells, acceleration of wound 
healing and reduction of blood cholesterol level8. 
It has also been investigated as a suitable 
polymer coating for oral delivery of 
proteins/peptide drugs 2, 4-6 as well as 
immobilization/delivery of living cells9 & 10. 
Chitosan is insoluble in aqueous, alkali and 
organic solvents. However, it is soluble in acid 
solutions when the pH is less than 6.0. Acetic 
acid and to a lesser extent, formic acid, are often 
commonly used for preparing chitosan solutions 
for encapsulation processes5-7. 
 
Drying is usually one of the final processes in 
drug production and is designed to yield a stable 
homogeneous product, which is easy to process 
in subsequent operations of packaging. Some 
examples of drying methods include freeze-
drying; spray-drying, fluidized-bed drying, oven-
drying and air-drying. The choice of drying 
method and equipment often depends on the 
heat sensitivity of the product, the physical 
characteristics prior to drying, the nature of 
solvent to be removed and the need for asepsis. 
The type of drying method employed may affect 
the properties of the final product11.  
 
The objective of this work is to study the effect of 
the type of acid solvent used in dissolving 
chitosan as well as drying method on the protein 
retention capacity of chitosan-alginate 
microcapsules. The solvents assessed are 
acetic acid, formic acid, hydrochloric acid and 
tartaric acid while the two drying methods 
evaluated were air-drying (at ambient 
temperature) and freeze-drying. 
 
Materials and Method 
Materials 
Sodium alginate (Kelco. Chicago IL) and 
chitosan (medium viscosity grade, Ransom 
Chem. Co., Redmond, WA) were the polymers 
used for microcapsule preparation. Bovine 
serum albumin (BSA) (used as a model protein) 
was obtained from Fluka AG Chem, Fabrik, 
Germany. Calcium chloride dihydrate and 
hydrochloric acid were obtained from BDH 
Chemicals, Toronto, Canada. All other chemicals 
used were of reagent grade. 
 
Method 
Preparation of encapsulation solutions 
Chitosan solution (0.1%) was prepared by 
dissolving 1 g of chitosan in 900 ml of distilled 
water containing 10 ml of glacial acetic acid with 
the aid of a magnetic stirrer. The molecular 
weight of the polymer, and hence the viscosity of 
its solution, were reduced by digesting overnight 
with 2.14 ml of 1% w/v sodium nitrite solution, i.e., 
based on a ratio of 0.05 mole sodium nitrite to 
1.0 mole chitosan6. 20 g of calcium chloride 
dihydrate was dissolved in the solution, 0.2ml 
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polysorbate was added (Tween 80) and its pH 
was adjusted to 5.5, using sodium hydroxide 
pellets and solution. The chitosan solution was 
then filtered and the volume adjusted to 1000 ml 
with distilled water. This foregoing procedure 
was repeated using formic acid, hydrochloric 
acid or tartaric acid in place of glacial acetic acid, 
except that the final pH was as follows; formic 
acid (5.85), hydrochloric acid (2.35) and tartaric 
acid (2.78). These represent, in each case, the 
maximum pH for chitosan solubility beyond 
which precipitation occurred. 
2.0 % w/v sodium alginate solution was prepared 
by dissolving 2.0 g of sodium alginate in distilled 
water using a magnetic stirrer. The volume was 
then adjusted to 100 ml. 
Microencapsulation of BSA 
10 ml of sodium alginate solution containing 
2.5% BSA was extruded into 70 ml of chitosan 
solution in a glass Petri dish from a 50 ml burette 
with a 1 mm diameter orifice. The extrusion 
distance, i.e., the distance between the burette 
tip and the surface of the chitosan solution, was 
fixed at 10 cm. On reaction with calcium ions 
(Ca2+) in the chitosan solution, the polyanionic 
sodium alginate droplets gel into calcium 
alginate beads, which then rapidly react with the 
polycationic chitosan. The resulting 
microcapsules were allowed an additional 
reaction time of 2 min following the termination 
of alginate extrusion, and then examined for size 
and shape consistency. The microcapsules were 
harvested by filtration using a nylon megh filter 
of 0.25 mm aperture size, washed twice with 
distilled water and then further rinsed quickly 
with isopropyl alcohol to remove as much water 
as possible. Approximately half of the 
microcapsules produced were dried using a 
freeze-dryer (Edwards Modulyo, England) at -
20oC and 608 mmHg for 3 h. The other half of 
wet microcapsules was air-dried in the laboratory 
for 24 h and conditioned over calcium sulphate 
granules (Drierite(R)) in a desiccator overnight. 
 
Protein retention studies 
About 200 mg dried microcapsules, accurately 
weighed, was placed in each of 300 ml wide-
mouthed bottles in a thermostated shaker bath 
(Gallenkamp) set at 30+0.5oC. 200 ml of the 
elution fluid, i.e., 0.1M HCL (pH 1.2) was put in 
each of the bottles and capped.  The shaker 
bath was agitated at a speed of 80 rpm and 
elution of BSA from the microcapsules was 
followed spectrophotometrically using Cecil CE 
202 UV/Visible spectrophotometer, Series 2 at 
λmax 280 nm. Protein retention was calculated as 
the difference between the microcapsule protein 
content prior to elution and the protein released 
after elution. All tests were carried out in 
quadruplicate. Assay of the microcapsules for 
the initial BSA content (load) was also carried 
out spectrophotometrically at 280 nm. 50 mg of 
the microcapsules was ‘citrated’ by dispersing in 
20 ml of 0.5M sodium citrate in scintillation vial 
and kept overnight. (Citration is used to break 
down the gel structure containing the entrapped 
protein6). The microcapsules, together with the 
citrate solution, were then transferred to a mortar 
and crushed with a pestle to effect maximum 
BSA release into solution. 
 
Results  
The effect of different acid solutions and drying 
methods on protein retention in chitosan-alginate 
microcapsules is shown in Figs 1-3. At pH 1.2 
(see Fig. 1), mean protein retention in 
microcapsules prepared with tartaric acid 
solution was 54% after 9 h compared to 35% for 
acetic acid, 31% for hydrochloric acid and 30% 
for formic acid over the same period. The effect 
of tartaric acid used in preparing chitosan 
solution on protein retention was found to be 
significantly different (p<0.05) from those 
prepared with other acids. When the pH of the 
release medium was increased to 5.0 (Fig. 2), 
there was a decrease in protein retention in all 
the microcapsules; tartaric acid had protein 
retention of 38% after 9 h, followed by 
microcapsules produced with formic acid, 36%; 
acetic acid solution had protein retention of 31%; 
and hydrochloric acid, 23%. Thus, there was no 
significant difference (p>0.05) in protein 
retention among the various acids used at pH 
5.0.                                                                                      
Protein retention was similar for both the freeze-
dried and air-dried microcapsules (Fig. 3) as  
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both groups of microcapsules had approximately 
50% protein retained after 5 h, and 32% and 
37%, protein retained for freeze-dried and air-
dried microcapsules, respectively, after 9 h.  
 
Discussion 
Effect of chitosan solvent type and elution 
pH 
Unmodified chitosan-alginate microcapsules 
have earlier been reported to be inadequate in 
retaining proteins in simulated gastric 
conditions12. In that work, acetic acid was used 
as the chitosan solvent. The findings from the 
present study show that the protein retention 
capacity of chitosan-alginate microcapsules may 
be influenced by the choice of chitosan solvent. 
A switch from acetic acid to tartaric acid led to 
enhancement of protein retention from 35% to 
54%. One factor that probably played a role here 
is the nature and degree of interaction between 
the solvent and chitosan. The greater the 
interaction between chitosan and solvent, the 
more compact and less porous the membrane. 
Acetic acid, with a pKa of 4.76, is less ionized in 
aqueous solution than tartaric acid which is a 
diprotic acid (pKa 2.8 and 4.3 for the two 
detachable hydrogen ions, respectively). 
Furthermore, tartaric acid, being diprotic, 
manifests two carboxyl (COO-) sites compared 
with one anionic site each for the other acids 
used. A combination of the two foregoing factors 
will result in enhanced chitosan-tartaric acid 
interaction (since chitosan is cationic) and hence 
a more compact and/or less porous membrane. 
The consequence is higher protein retention 
capacity arising from reduced protein diffusion 
from the microcapsules. Another contributory 
factor may be deduced from a recent study, 
which attributed the poor protein retention 
capacity of unmodified chitosan-alginate 
microcapsules in pH 1.2 medium to rapid 
dissolution of the chitosan membrane leading to 
rapid protein elution from the exposed alginate 
core12. It is likely that the chitosan membrane 
formed with the tartaric acid, being more 
compact, stronger and less porous, is less 
susceptible to acid-induced dissolution at pH 1.2 
and, therefore, demonstrated a higher capacity 
to slow down protein elution from the alginate 
core than the chitosan membrane formed with 
acetic acid. 
 
HCl, being completely ionized in water, unlike 
the other acids used, would ordinarily have been 
expected to interact most strongly with the 
cationic chitosan via its Cl -  resulting in the most 
compact and least porous membrane, and 
hence the highest protein retention. The fact that 
this is not the case may be due to the inorganic 
character of Cl - which is not only mobile but 
lacks the hydrocarbon backbone of the organic 
anions. 
 
Interestingly, tartaric acid seemed to have lost a 
significant portion of its effect on protein 
retention in pH 5 elution medium. In fact, 
statistical analysis showed that there was no 
significant difference (p>0.05) in the protein 
retention capacity of the microcapsules prepared 
with the four acid solvents. The reason for this is 
not immediately clear. However, earlier studies 5 
indicate that at ≥ pH 3 elution fluid, chitosan 
membrane remains largely uneroded 
(undissolved) unlike at pH 1.2. Thus the 
membrane pores, protein diffusivity across the 


















Fig. 1: BSA retention at pH 1.2 in unmodified chitosan-
alginate microcapsules formulated with chitosan dissolved 
in solutions of various acids. (Key: acetic acid [♦], formic 
acid [∆], tartaric acid [ ] and hydrochloric acid [x]). 
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protein transport through the diffusion pathways 
of the alginate matrix itself would determine the 
level of protein retention. The relative impact of 
these three factors (membrane pores, diffusion 
across the alginate-chitosan interface and 




Effect of drying 
After drying, the microcapsules reduced to 
about one-third their original size. Freeze-drying 
was faster (about 3 h) than air-drying at 
ambient temperature (over 24 h). However, the 
release profiles for both the freeze-dried 
microcapsules and the air-dried microcapsules 
were similar. It would appear that the drying 
method used did not exert any structural, 
molecular and/or morphological effects on the 
microcapsules that would be irreversible when 
the dry microcapsules were rehydrated in 




Microcapsules produced with chitosan solution 
of tartaric acid had better protein retention than 
those produced using chitosan solutions of 
acetic acid, formic acid and hydrochloric acid, 
respectively. When the elution pH was raised 
from 1.2 to 5.0, there was no significant change 
(p>0.05) in protein retention except for 
microcapsules prepared with chitosan dissolved 
in tartaric acid, which showed a drop in protein 
retention. It was also observed that the drying 
method used (air-drying or freeze-drying) did 
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Fig.2: BSA retention in unmodified chitosan-
alginate microcapsules at pH 5 formulated with 
chitosan dissolved in solutions of various acids. 
(Key: acetic acid [♦], formic acid [∆], tartaric 



















Fig. 3: Effect of drying method on BSA  
retention from chitosan-alginate microcapsules  
at pH 1.2. (Key: air-dried [▲], freeze-dried [ ]) 
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